Company intelligence / Profile preview

IOL Chemicals and Pharmaceuticals

Ludhiana, Punjab, Indiaiolcp.com ↗

Ownership: Private
Employees: ~2500
Development stage: Commercial

Overview

IOL Chemicals and Pharmaceuticals is a leading Indian manufacturer of active pharmaceutical ingredients and specialty chemicals. It holds a ~35% global market share in ibuprofen production and has significant commercial scale for APIs such as metformin hydrochloride. The company’s products are approved by major regulatory agencies including USFDA and NMPA China. It has expanded its portfolio to include several generic APIs across multiple therapeutic areas

Therapeutic areas: EndocrinologyImmunologyOtherGastroenterologyCardiovascularNeurology
Modalities: Small molecule
Industry: Chemicals & Materials

Drug pipeline

7 assets

ibuprofen

Commercial

Indications: Pain management

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on IOL Chemicals and Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IOL Chemicals and Pharmaceuticals.

Explore the full profile